Tag: market

Posted on

Research and Markets: Roche’s Quilizumab (Asthma) – Forecast and Market … – Business Wire (press release)

Research and Markets: Roche's Quilizumab (Asthma) – Forecast and Market …
Business Wire (press release)
IgE is important in the development of allergic asthma, as it binds to mast cells and basophils, which play a significant role in the pathogenesis of asthma. IgE ultimately triggers the release of histamines, prostaglandins, and leukotrienes, which …
Research and Markets: Cinquil (Reslizumab) Asthma Treatment – Forecast and …Rock Hill Herald (press release)
Research and Markets: Roche's Lebrikizumab (Asthma) Treatment – Forecast …DigitalJournal.com

all 3 news articles »

View full post on asthma – Google News

Posted on

Report: Asthma market to remain stable during next decade – Healio

Report: Asthma market to remain stable during next decade
Healio
The asthma market is projected to remain stable in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan with a slight increase from $15.1 billion in 2013 to $16.1 billion in 2023, according to a report from Decision Resources …
Asthma market to remain stable over next decade, despite generic erosionThe Pharma Letter

all 2 news articles »

View full post on asthma – Google News

Posted on

Asthma market to remain stable over next decade, despite generic erosion – The Pharma Letter


The Pharma Letter

Asthma market to remain stable over next decade, despite generic erosion
The Pharma Letter
New market potential in underserved asthma population: Emerging anticytokines that are predicted to launch during the next decade will serve part of the unmet need in the severe, refractory asthma population, which is currently served by only systemic …

View full post on asthma – Google News

Posted on

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite … – The Providence Journal

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite …
The Providence Journal
BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain …

and more »

View full post on asthma – Google News

Posted on

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite … – MarketWatch

The Asthma Market Is Forecast to Remain Stable over the Next Decade, Despite …
MarketWatch
BURLINGTON, Mass., Oct. 8, 2014 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain stable, increasing slightly from $15.1 billion in 2013 to $16.1 billion in 2023 in the United States, France, Germany, Italy, Spain …

View full post on asthma – Google News

Posted on

PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023 – MarketWatch

PharmaPoint: Asthma – Japan Drug Forecast and Market Analysis to 2023
MarketWatch
Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with …

and more »

View full post on asthma – Google News

Posted on

Research and Markets: PharmaPoint: Asthma – 5EU Drug Forecast and Market … – Rock Hill Herald (press release)

Research and Markets: PharmaPoint: Asthma – 5EU Drug Forecast and Market …
Rock Hill Herald (press release)
The relatively slow growth of the German market compared with the French, Spanish, and UK markets is attributable to the slightly decreasing prevalence of asthma in this country over the forecast period. Advair's active patent on the Diskus delivery …

and more »

View full post on asthma – Google News